Large-scale testing (Phase 3)Study completedNCT02042014
What this trial is testing
Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
Who this might be right for
Severe Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 8